Darnytsia Pharmaceutical Company participated in the international UA–EU Partnership: Pharmaceutical Sector conference, organized by the Ministry of Health of Ukraine and the Ministry of Economy with support from European institutions.
The event brought together leaders from the pharmaceutical industry and representatives of key EU organizations. A central discussion panel explored the potential and competitiveness of Ukrainian pharmaceutical manufacturers in the European context, as well as Ukraine’s integration into global supply chains for critical medicines.
“Today, Europe is reassessing Ukraine — not as a risk zone, but as a source of robust resources, partnership, and investment. The Ukrainian pharmaceutical sector has already demonstrated its competitiveness and readiness to meet the highest standards in manufacturing quality and logistics. Our aim is not only to strengthen the domestic market, but also to fully integrate Ukraine into the European medicines supply system. This will enhance the resilience of our country and the entire region,” emphasized Kostiantyn Vashchenko, Government Relations Director at Darnytsia.
During the conference, Darnytsia showcased its production capabilities and modern manufacturing solutions, highlighting its readiness for full integration into European supply chains for critical medicines. The company also conducted a series of constructive meetings with representatives of European organizations.
The strong interest in Ukrainian manufacturers, productive exchange of expertise, and recognition of Ukraine as a reliable partner confirmed that the integration of Ukrainian pharmaceuticals into the European system is both mutually beneficial and strategically important.
Darnytsia expresses its gratitude to the organizers and European partners for the opportunity to participate in this professional dialogue and remains committed to strengthening international cooperation in the healthcare sector.
